BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21659666)

  • 21. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.
    Casas F; Valduvieco I; Oses G; Izquierdo L; Archila I; Costa M; Cortes KS; Barreto T; Ferrer F
    Clin Transl Oncol; 2019 Mar; 21(3):355-362. PubMed ID: 30128953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy.
    Schaufler C; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim S; Bellmunt J; Kaplan I; Olumi AF; Gershman B
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):81-88. PubMed ID: 36434164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.
    Catton C; Gospodarowicz M; Warde P; Panzarella T; Catton P; McLean M; Milosevic M
    Radiother Oncol; 2001 Apr; 59(1):51-60. PubMed ID: 11295206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.
    Gore JL; du Plessis M; Santiago-Jiménez M; Yousefi K; Thompson DJS; Karsh L; Lane BR; Franks M; Chen DYT; Bandyk M; Bianco FJ; Brown G; Clark W; Kibel AS; Kim HL; Lowrance W; Manoharan M; Maroni P; Perrapato S; Sieber P; Trabulsi EJ; Waterhouse R; Davicioni E; Lotan Y; Lin DW
    Cancer; 2017 Aug; 123(15):2850-2859. PubMed ID: 28422278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
    Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
    Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era.
    Lobo JM; Stukenborg GJ; Trifiletti DM; Patel N; Showalter TN
    J Comp Eff Res; 2016 Jul; 5(4):375-82. PubMed ID: 27294829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.
    Tao R; Dai J; Bai Y; Yang J; Sun G; Zhang X; Zhao J; Zeng H; Shen P
    Radiat Oncol; 2019 Nov; 14(1):197. PubMed ID: 31706339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
    Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
    J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of risk-prediction tools in selecting patients for immediate post-prostatectomy treatment.
    Zubek VB; Konski A
    Mol Diagn Ther; 2009; 13(1):31-47. PubMed ID: 19351214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy.
    Vogel MME; Kessel KA; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
    Strahlenther Onkol; 2019 Feb; 195(2):131-144. PubMed ID: 30182246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
    Vale CL; Fisher D; Kneebone A; Parker C; Pearse M; Richaud P; Sargos P; Sydes MR; Brawley C; Brihoum M; Brown C; Chabaud S; Cook A; Forcat S; Fraser-Browne C; Latorzeff I; Parmar MKB; Tierney JF;
    Lancet; 2020 Oct; 396(10260):1422-1431. PubMed ID: 33002431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
    Draulans C; Van Damme N; Isebaert S; Everaerts W; Silversmit G; Joniau S; De Meerleer G; Van Eycken E; Haustermans K;
    Acta Oncol; 2020 Aug; 59(8):904-910. PubMed ID: 32723224
    [No Abstract]   [Full Text] [Related]  

  • 34. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
    Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.
    Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Lee PA; McMahon PM
    Ann Intern Med; 2013 Jun; 158(12):853-60. PubMed ID: 23778902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.
    Cooperberg MR; Ramakrishna NR; Duff SB; Hughes KE; Sadownik S; Smith JA; Tewari AK
    BJU Int; 2013 Mar; 111(3):437-50. PubMed ID: 23279038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant and salvage radiotherapy after radical prostatectomy.
    Höcht S; Wiegel T; Schostak M; Hinkelbein W
    Onkologie; 2002 Jun; 25(3):201-6. PubMed ID: 12119453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
    Gandaglia G; Briganti A; Clarke N; Karnes RJ; Graefen M; Ost P; Zietman AL; Roach M
    Eur Urol; 2017 Nov; 72(5):689-709. PubMed ID: 28189428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.
    Showalter TN; Ohri N; Teti KG; Foley KA; Keith SW; Trabulsi EJ; Lallas CD; Dicker AP; Hoffman-Censits J; Pizzi LT; Gomella LG
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e233-8. PubMed ID: 21605945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy.
    Budiharto T; Perneel C; Haustermans K; Junius S; Tombal B; Scalliet P; Renard L; Lerut E; Vekemans K; Joniau S; Van Poppel H
    Radiother Oncol; 2010 Dec; 97(3):474-9. PubMed ID: 20950879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.